At Israelites Pharma Pvt Ltd, we focus on delivering safe, high-quality, and innovative pharmaceutical solutions worldwide.
VOGLITYT GM 1 is a triple-action antidiabetic formulation designed to control blood sugar levels effectively and promote cardiovascular wellness. Combining Voglibose, Glimepiride, and Metformin, it supports long-term diabetic health and improves metabolic balance. Trusted by healthcare professionals for reliable glucose control and patient safety.
| Attribute | VOGLITYT GM 1 | VOGLITYT GM 2 |
|---|---|---|
| Dosage Form | Tablet | Tablet |
| Strength | 1 MG | 2 MG |
| Active Ingredients | Voglibose 0.2 MG + Glimepiride 1 MG + Metformin 500 MG | Voglibose 0.2 MG + Glimepiride 2 MG + Metformin 500 MG |
| Packaging Options | 15 Tablets per Strip, 10 Strips in Box | 15 Tablets per Strip, 10 Strips in Box |
| Therapeutic Area | Cardiovascular / Diabetic | Cardiovascular / Diabetic |
| Color Composition | Red Oxide of Iron | Yellow Oxide of Iron |
| Storage | Cool, dry place | Cool, dry place |
| Recommended Use | As directed by healthcare professional | As directed by healthcare professional |
| Manufacturer | Akums Drugs & Pharmaceuticals Ltd, Uttarakhand, India | Akums Drugs & Pharmaceuticals Ltd, Uttarakhand, India |
| Marketer | Israelites Pharma Pvt Ltd, A/321, Royal Palms, Goregaon East, Mumbai, Maharashtra – 400065 | Israelites Pharma Pvt Ltd, A/321, Royal Palms, Goregaon East, Mumbai, Maharashtra – 400065 |
| Image / Documents | Link | Link |
VOGLITYT GM 1 and VOGLITYT GM 2 are manufactured by Akums Drugs & Pharmaceuticals Ltd, located in Uttarakhand, India. The facility follows Good Manufacturing Practices (GMP) to ensure every batch meets the highest standards of quality, purity, and efficacy.
Marketed by Israelites Pharma Pvt Ltd,
A/321, Royal Palms, Goregaon East, Mumbai, Maharashtra – 400065, India.
Committed to delivering safe, affordable, and effective healthcare solutions globally.
Each batch of VOGLITYT GM 1 (Voglibose 0.2 MG + Glimepiride 1 MG + Metformin 500 MG) and VOGLITYT GM 2 (Voglibose 0.2 MG + Glimepiride 2 MG + Metformin 500 MG) undergoes stringent quality control checks to ensure purity, stability, and therapeutic efficacy. The facility operates under strict Good Manufacturing Practices (GMP) and follows Standard Operating Procedures (SOPs) for formulation, coating, and packaging, overseen by a team of qualified pharmaceutical experts.
The company’s R&D division continuously innovates in antidiabetic formulations and fixed-dose combinations, focusing on improving glycemic control and cardiovascular safety. Each formulation is designed to support effective type 2 diabetes management through synergistic ingredient action.
Israelites Pharma is committed to patient health and ethical manufacturing. All VOGLITYT products are produced using VEG-based excipients and coated with approved coloring agents such as Red Oxide of Iron (GM 1) and Yellow Oxide of Iron (GM 2). The company emphasizes safe usage guidance, medical accuracy, and continuous product improvement for healthcare professionals and patients alike.
WhatsApp us